Home Secura Bio

Secura Bio

In operation
Debt Financing
Tumor Therapy Developer
Basic
Enterprise Profile

Basic Information

Secura Bio is an integrated biopharmaceutical company dedicated to the global commercialization of critical oncology therapies for physicians and their patients. Headquartered in Henderson, Nevada, the company operates in the United States and has an office in San Diego. Currently, Secura Bio's main drug product is FARYDAK®.
Secura Bio, Inc.
United States of America
less than 15 people
January 01, 2019
MARK.SPRING@SECURABIO.COM

Enterprise Profile

Industrial Sector
New Drug Development
Concept
Tumor Therapeutic Products Lymphoma Leukemia
Application Scenarios
Innovative Drugs